Global Single Cell Multi-Omics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 279599
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Single Cell Multi-Omics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Single Cell Multi-Omics market size is estimated to be worth US$ 1863 million in 2021 and is forecast to a readjusted size of USD 3383.9 million by 2028 with a CAGR of 8.9% during review period. Oncology accounting for % of the Single Cell Multi-Omics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Cell Genomics segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Single Cell Multi-Omics include 10x Genomics, 1CellBio, MissionBio, NanoString Technologies, and Fluidigm Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Single Cell Multi-Omics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Single Cell Genomics

Single Cell Proteomics

Single Cell Transcriptomics

Single Cell Metabolomics

Market segment by Application, can be divided into

Oncology

Cell Biology

Neurology

Immunology

Others

Market segment by players, this report covers

10x Genomics

1CellBio

MissionBio

NanoString Technologies

Fluidigm Corporation

Fluxion Biosciences

Bio-Rad Laboratories

Celsee

BGI Genomics

GE LifeSciences

Illumina

Takara Bio

QIAGEN N.V.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Single Cell Multi-Omics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Single Cell Multi-Omics, with revenue, gross margin and global market share of Single Cell Multi-Omics from 2019 to 2022.

Chapter 3, the Single Cell Multi-Omics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Single Cell Multi-Omics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Single Cell Multi-Omics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Single Cell Multi-Omics

1.2 Classification of Single Cell Multi-Omics by Type

1.2.1 Overview: Global Single Cell Multi-Omics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Single Cell Multi-Omics Revenue Market Share by Type in 2021

1.2.3 Single Cell Genomics

1.2.4 Single Cell Proteomics

1.2.5 Single Cell Transcriptomics

1.2.6 Single Cell Metabolomics

1.3 Global Single Cell Multi-Omics Market by Application

1.3.1 Overview: Global Single Cell Multi-Omics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Oncology

1.3.3 Cell Biology

1.3.4 Neurology

1.3.5 Immunology

1.3.6 Others

1.4 Global Single Cell Multi-Omics Market Size & Forecast

1.5 Global Single Cell Multi-Omics Market Size and Forecast by Region

1.5.1 Global Single Cell Multi-Omics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Single Cell Multi-Omics Market Size by Region, (2017-2022)

1.5.3 North America Single Cell Multi-Omics Market Size and Prospect (2017-2028)

1.5.4 Europe Single Cell Multi-Omics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Single Cell Multi-Omics Market Size and Prospect (2017-2028)

1.5.6 South America Single Cell Multi-Omics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Single Cell Multi-Omics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Single Cell Multi-Omics Market Drivers

1.6.2 Single Cell Multi-Omics Market Restraints

1.6.3 Single Cell Multi-Omics Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 10x Genomics

2.1.1 10x Genomics Details

2.1.2 10x Genomics Major Business

2.1.3 10x Genomics Single Cell Multi-Omics Product and Solutions

2.1.4 10x Genomics Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 10x Genomics Recent Developments and Future Plans

2.2 1CellBio

2.2.1 1CellBio Details

2.2.2 1CellBio Major Business

2.2.3 1CellBio Single Cell Multi-Omics Product and Solutions

2.2.4 1CellBio Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 1CellBio Recent Developments and Future Plans

2.3 MissionBio

2.3.1 MissionBio Details

2.3.2 MissionBio Major Business

2.3.3 MissionBio Single Cell Multi-Omics Product and Solutions

2.3.4 MissionBio Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 MissionBio Recent Developments and Future Plans

2.4 NanoString Technologies

2.4.1 NanoString Technologies Details

2.4.2 NanoString Technologies Major Business

2.4.3 NanoString Technologies Single Cell Multi-Omics Product and Solutions

2.4.4 NanoString Technologies Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 NanoString Technologies Recent Developments and Future Plans

2.5 Fluidigm Corporation

2.5.1 Fluidigm Corporation Details

2.5.2 Fluidigm Corporation Major Business

2.5.3 Fluidigm Corporation Single Cell Multi-Omics Product and Solutions

2.5.4 Fluidigm Corporation Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Fluidigm Corporation Recent Developments and Future Plans

2.6 Fluxion Biosciences

2.6.1 Fluxion Biosciences Details

2.6.2 Fluxion Biosciences Major Business

2.6.3 Fluxion Biosciences Single Cell Multi-Omics Product and Solutions

2.6.4 Fluxion Biosciences Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Fluxion Biosciences Recent Developments and Future Plans

2.7 Bio-Rad Laboratories

2.7.1 Bio-Rad Laboratories Details

2.7.2 Bio-Rad Laboratories Major Business

2.7.3 Bio-Rad Laboratories Single Cell Multi-Omics Product and Solutions

2.7.4 Bio-Rad Laboratories Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.8 Celsee

2.8.1 Celsee Details

2.8.2 Celsee Major Business

2.8.3 Celsee Single Cell Multi-Omics Product and Solutions

2.8.4 Celsee Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Celsee Recent Developments and Future Plans

2.9 BGI Genomics

2.9.1 BGI Genomics Details

2.9.2 BGI Genomics Major Business

2.9.3 BGI Genomics Single Cell Multi-Omics Product and Solutions

2.9.4 BGI Genomics Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 BGI Genomics Recent Developments and Future Plans

2.10 GE LifeSciences

2.10.1 GE LifeSciences Details

2.10.2 GE LifeSciences Major Business

2.10.3 GE LifeSciences Single Cell Multi-Omics Product and Solutions

2.10.4 GE LifeSciences Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 GE LifeSciences Recent Developments and Future Plans

2.11 Illumina

2.11.1 Illumina Details

2.11.2 Illumina Major Business

2.11.3 Illumina Single Cell Multi-Omics Product and Solutions

2.11.4 Illumina Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Illumina Recent Developments and Future Plans

2.12 Takara Bio

2.12.1 Takara Bio Details

2.12.2 Takara Bio Major Business

2.12.3 Takara Bio Single Cell Multi-Omics Product and Solutions

2.12.4 Takara Bio Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Takara Bio Recent Developments and Future Plans

2.13 QIAGEN N.V.

2.13.1 QIAGEN N.V. Details

2.13.2 QIAGEN N.V. Major Business

2.13.3 QIAGEN N.V. Single Cell Multi-Omics Product and Solutions

2.13.4 QIAGEN N.V. Single Cell Multi-Omics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 QIAGEN N.V. Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Single Cell Multi-Omics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Single Cell Multi-Omics Players Market Share in 2021

3.2.2 Top 10 Single Cell Multi-Omics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Single Cell Multi-Omics Players Head Office, Products and Services Provided

3.4 Single Cell Multi-Omics Mergers & Acquisitions

3.5 Single Cell Multi-Omics New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Single Cell Multi-Omics Revenue and Market Share by Type (2017-2022)

4.2 Global Single Cell Multi-Omics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Single Cell Multi-Omics Revenue Market Share by Application (2017-2022)

5.2 Global Single Cell Multi-Omics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Single Cell Multi-Omics Revenue by Type (2017-2028)

6.2 North America Single Cell Multi-Omics Revenue by Application (2017-2028)

6.3 North America Single Cell Multi-Omics Market Size by Country

6.3.1 North America Single Cell Multi-Omics Revenue by Country (2017-2028)

6.3.2 United States Single Cell Multi-Omics Market Size and Forecast (2017-2028)

6.3.3 Canada Single Cell Multi-Omics Market Size and Forecast (2017-2028)

6.3.4 Mexico Single Cell Multi-Omics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Single Cell Multi-Omics Revenue by Type (2017-2028)

7.2 Europe Single Cell Multi-Omics Revenue by Application (2017-2028)

7.3 Europe Single Cell Multi-Omics Market Size by Country

7.3.1 Europe Single Cell Multi-Omics Revenue by Country (2017-2028)

7.3.2 Germany Single Cell Multi-Omics Market Size and Forecast (2017-2028)

7.3.3 France Single Cell Multi-Omics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Single Cell Multi-Omics Market Size and Forecast (2017-2028)

7.3.5 Russia Single Cell Multi-Omics Market Size and Forecast (2017-2028)

7.3.6 Italy Single Cell Multi-Omics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Single Cell Multi-Omics Revenue by Type (2017-2028)

8.2 Asia-Pacific Single Cell Multi-Omics Revenue by Application (2017-2028)

8.3 Asia-Pacific Single Cell Multi-Omics Market Size by Region

8.3.1 Asia-Pacific Single Cell Multi-Omics Revenue by Region (2017-2028)

8.3.2 China Single Cell Multi-Omics Market Size and Forecast (2017-2028)

8.3.3 Japan Single Cell Multi-Omics Market Size and Forecast (2017-2028)

8.3.4 South Korea Single Cell Multi-Omics Market Size and Forecast (2017-2028)

8.3.5 India Single Cell Multi-Omics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Single Cell Multi-Omics Market Size and Forecast (2017-2028)

8.3.7 Australia Single Cell Multi-Omics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Single Cell Multi-Omics Revenue by Type (2017-2028)

9.2 South America Single Cell Multi-Omics Revenue by Application (2017-2028)

9.3 South America Single Cell Multi-Omics Market Size by Country

9.3.1 South America Single Cell Multi-Omics Revenue by Country (2017-2028)

9.3.2 Brazil Single Cell Multi-Omics Market Size and Forecast (2017-2028)

9.3.3 Argentina Single Cell Multi-Omics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Single Cell Multi-Omics Revenue by Type (2017-2028)

10.2 Middle East & Africa Single Cell Multi-Omics Revenue by Application (2017-2028)

10.3 Middle East & Africa Single Cell Multi-Omics Market Size by Country

10.3.1 Middle East & Africa Single Cell Multi-Omics Revenue by Country (2017-2028)

10.3.2 Turkey Single Cell Multi-Omics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Single Cell Multi-Omics Market Size and Forecast (2017-2028)

10.3.4 UAE Single Cell Multi-Omics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Single Cell Multi-Omics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Single Cell Multi-Omics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Single Cell Multi-Omics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Single Cell Multi-Omics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Single Cell Multi-Omics Revenue Market Share by Region (2023-2028)

Table 6. 10x Genomics Corporate Information, Head Office, and Major Competitors

Table 7. 10x Genomics Major Business

Table 8. 10x Genomics Single Cell Multi-Omics Product and Solutions

Table 9. 10x Genomics Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. 1CellBio Corporate Information, Head Office, and Major Competitors

Table 11. 1CellBio Major Business

Table 12. 1CellBio Single Cell Multi-Omics Product and Solutions

Table 13. 1CellBio Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. MissionBio Corporate Information, Head Office, and Major Competitors

Table 15. MissionBio Major Business

Table 16. MissionBio Single Cell Multi-Omics Product and Solutions

Table 17. MissionBio Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. NanoString Technologies Corporate Information, Head Office, and Major Competitors

Table 19. NanoString Technologies Major Business

Table 20. NanoString Technologies Single Cell Multi-Omics Product and Solutions

Table 21. NanoString Technologies Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Fluidigm Corporation Corporate Information, Head Office, and Major Competitors

Table 23. Fluidigm Corporation Major Business

Table 24. Fluidigm Corporation Single Cell Multi-Omics Product and Solutions

Table 25. Fluidigm Corporation Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Fluxion Biosciences Corporate Information, Head Office, and Major Competitors

Table 27. Fluxion Biosciences Major Business

Table 28. Fluxion Biosciences Single Cell Multi-Omics Product and Solutions

Table 29. Fluxion Biosciences Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 31. Bio-Rad Laboratories Major Business

Table 32. Bio-Rad Laboratories Single Cell Multi-Omics Product and Solutions

Table 33. Bio-Rad Laboratories Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Celsee Corporate Information, Head Office, and Major Competitors

Table 35. Celsee Major Business

Table 36. Celsee Single Cell Multi-Omics Product and Solutions

Table 37. Celsee Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. BGI Genomics Corporate Information, Head Office, and Major Competitors

Table 39. BGI Genomics Major Business

Table 40. BGI Genomics Single Cell Multi-Omics Product and Solutions

Table 41. BGI Genomics Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. GE LifeSciences Corporate Information, Head Office, and Major Competitors

Table 43. GE LifeSciences Major Business

Table 44. GE LifeSciences Single Cell Multi-Omics Product and Solutions

Table 45. GE LifeSciences Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Illumina Corporate Information, Head Office, and Major Competitors

Table 47. Illumina Major Business

Table 48. Illumina Single Cell Multi-Omics Product and Solutions

Table 49. Illumina Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Takara Bio Corporate Information, Head Office, and Major Competitors

Table 51. Takara Bio Major Business

Table 52. Takara Bio Single Cell Multi-Omics Product and Solutions

Table 53. Takara Bio Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. QIAGEN N.V. Corporate Information, Head Office, and Major Competitors

Table 55. QIAGEN N.V. Major Business

Table 56. QIAGEN N.V. Single Cell Multi-Omics Product and Solutions

Table 57. QIAGEN N.V. Single Cell Multi-Omics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global Single Cell Multi-Omics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global Single Cell Multi-Omics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of Single Cell Multi-Omics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Single Cell Multi-Omics Players Head Office, Products and Services Provided

Table 62. Single Cell Multi-Omics Mergers & Acquisitions in the Past Five Years

Table 63. Single Cell Multi-Omics New Entrants and Expansion Plans

Table 64. Global Single Cell Multi-Omics Revenue (USD Million) by Type (2017-2022)

Table 65. Global Single Cell Multi-Omics Revenue Share by Type (2017-2022)

Table 66. Global Single Cell Multi-Omics Revenue Forecast by Type (2023-2028)

Table 67. Global Single Cell Multi-Omics Revenue by Application (2017-2022)

Table 68. Global Single Cell Multi-Omics Revenue Forecast by Application (2023-2028)

Table 69. North America Single Cell Multi-Omics Revenue by Type (2017-2022) & (USD Million)

Table 70. North America Single Cell Multi-Omics Revenue by Type (2023-2028) & (USD Million)

Table 71. North America Single Cell Multi-Omics Revenue by Application (2017-2022) & (USD Million)

Table 72. North America Single Cell Multi-Omics Revenue by Application (2023-2028) & (USD Million)

Table 73. North America Single Cell Multi-Omics Revenue by Country (2017-2022) & (USD Million)

Table 74. North America Single Cell Multi-Omics Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe Single Cell Multi-Omics Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe Single Cell Multi-Omics Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe Single Cell Multi-Omics Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe Single Cell Multi-Omics Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe Single Cell Multi-Omics Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe Single Cell Multi-Omics Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific Single Cell Multi-Omics Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific Single Cell Multi-Omics Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific Single Cell Multi-Omics Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific Single Cell Multi-Omics Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific Single Cell Multi-Omics Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific Single Cell Multi-Omics Revenue by Region (2023-2028) & (USD Million)

Table 87. South America Single Cell Multi-Omics Revenue by Type (2017-2022) & (USD Million)

Table 88. South America Single Cell Multi-Omics Revenue by Type (2023-2028) & (USD Million)

Table 89. South America Single Cell Multi-Omics Revenue by Application (2017-2022) & (USD Million)

Table 90. South America Single Cell Multi-Omics Revenue by Application (2023-2028) & (USD Million)

Table 91. South America Single Cell Multi-Omics Revenue by Country (2017-2022) & (USD Million)

Table 92. South America Single Cell Multi-Omics Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa Single Cell Multi-Omics Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa Single Cell Multi-Omics Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa Single Cell Multi-Omics Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa Single Cell Multi-Omics Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa Single Cell Multi-Omics Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa Single Cell Multi-Omics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Single Cell Multi-Omics Picture

Figure 2. Global Single Cell Multi-Omics Revenue Market Share by Type in 2021

Figure 3. Single Cell Genomics

Figure 4. Single Cell Proteomics

Figure 5. Single Cell Transcriptomics

Figure 6. Single Cell Metabolomics

Figure 7. Single Cell Multi-Omics Revenue Market Share by Application in 2021

Figure 8. Oncology Picture

Figure 9. Cell Biology Picture

Figure 10. Neurology Picture

Figure 11. Immunology Picture

Figure 12. Others Picture

Figure 13. Global Single Cell Multi-Omics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 14. Global Single Cell Multi-Omics Revenue and Forecast (2017-2028) & (USD Million)

Figure 15. Global Single Cell Multi-Omics Revenue Market Share by Region (2017-2028)

Figure 16. Global Single Cell Multi-Omics Revenue Market Share by Region in 2021

Figure 17. North America Single Cell Multi-Omics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Europe Single Cell Multi-Omics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Asia-Pacific Single Cell Multi-Omics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. South America Single Cell Multi-Omics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Middle East and Africa Single Cell Multi-Omics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Single Cell Multi-Omics Market Drivers

Figure 23. Single Cell Multi-Omics Market Restraints

Figure 24. Single Cell Multi-Omics Market Trends

Figure 25. 10x Genomics Recent Developments and Future Plans

Figure 26. 1CellBio Recent Developments and Future Plans

Figure 27. MissionBio Recent Developments and Future Plans

Figure 28. NanoString Technologies Recent Developments and Future Plans

Figure 29. Fluidigm Corporation Recent Developments and Future Plans

Figure 30. Fluxion Biosciences Recent Developments and Future Plans

Figure 31. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 32. Celsee Recent Developments and Future Plans

Figure 33. BGI Genomics Recent Developments and Future Plans

Figure 34. GE LifeSciences Recent Developments and Future Plans

Figure 35. Illumina Recent Developments and Future Plans

Figure 36. Takara Bio Recent Developments and Future Plans

Figure 37. QIAGEN N.V. Recent Developments and Future Plans

Figure 38. Global Single Cell Multi-Omics Revenue Share by Players in 2021

Figure 39. Single Cell Multi-Omics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 40. Global Top 3 Players Single Cell Multi-Omics Revenue Market Share in 2021

Figure 41. Global Top 10 Players Single Cell Multi-Omics Revenue Market Share in 2021

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 43. Global Single Cell Multi-Omics Revenue Share by Type in 2021

Figure 44. Global Single Cell Multi-Omics Market Share Forecast by Type (2023-2028)

Figure 45. Global Single Cell Multi-Omics Revenue Share by Application in 2021

Figure 46. Global Single Cell Multi-Omics Market Share Forecast by Application (2023-2028)

Figure 47. North America Single Cell Multi-Omics Sales Market Share by Type (2017-2028)

Figure 48. North America Single Cell Multi-Omics Sales Market Share by Application (2017-2028)

Figure 49. North America Single Cell Multi-Omics Revenue Market Share by Country (2017-2028)

Figure 50. United States Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Canada Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Mexico Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Europe Single Cell Multi-Omics Sales Market Share by Type (2017-2028)

Figure 54. Europe Single Cell Multi-Omics Sales Market Share by Application (2017-2028)

Figure 55. Europe Single Cell Multi-Omics Revenue Market Share by Country (2017-2028)

Figure 56. Germany Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. France Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. United Kingdom Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Russia Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Italy Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Asia-Pacific Single Cell Multi-Omics Sales Market Share by Type (2017-2028)

Figure 62. Asia-Pacific Single Cell Multi-Omics Sales Market Share by Application (2017-2028)

Figure 63. Asia-Pacific Single Cell Multi-Omics Revenue Market Share by Region (2017-2028)

Figure 64. China Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Japan Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South Korea Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. India Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Southeast Asia Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Australia Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. South America Single Cell Multi-Omics Sales Market Share by Type (2017-2028)

Figure 71. South America Single Cell Multi-Omics Sales Market Share by Application (2017-2028)

Figure 72. South America Single Cell Multi-Omics Revenue Market Share by Country (2017-2028)

Figure 73. Brazil Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Argentina Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Middle East and Africa Single Cell Multi-Omics Sales Market Share by Type (2017-2028)

Figure 76. Middle East and Africa Single Cell Multi-Omics Sales Market Share by Application (2017-2028)

Figure 77. Middle East and Africa Single Cell Multi-Omics Revenue Market Share by Country (2017-2028)

Figure 78. Turkey Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Saudi Arabia Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. UAE Single Cell Multi-Omics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source